• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM 0.00% 2.9¢

CHIMERIC THERAPEUTICS LIMITED

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase I clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of four NK and CAR NK assets with plans for Phase I clinical trials in solid tumors and blood cancers.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM
Chimeric: Media Thread
10 11 12
06:17 692 274K
06:17 Last post  pinch2020 Comments Created with Sketch.  692  Views Created with Sketch.  274K 
CHM 02/05/24 59 14K
02/05/24 Last post  1MRX Comments Created with Sketch.  59  Views Created with Sketch.  14K 
CHM 02/05/24 13 3.1K
Metals & Mining SECTOR NEWS

8th Regional Uranium Anomaly Confirmed at Saraya Project - Potential for new discoveries still exists!

HAR
03 May 2024
HARANGA RESOURCES LIMITED.
02/05/24 Last post  Nickporthcawl Comments Created with Sketch.  13  Views Created with Sketch.  3.1K 
CHM 02/05/24 0 206
02/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  206 
CHM 02/05/24 0 175
02/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  175 
CHM
New email reg. JC
02/05/24 12 3.0K
02/05/24 Last post  F18FDG Comments Created with Sketch.  12  Views Created with Sketch.  3.0K 
CHM
News: CHM Chimeric Therapeutics Says Jennifer Chow Gave Notice Of Resignation As CEO, Managing...
01/05/24 0 219
01/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  219 
CHM 30/04/24 6 1.6K
30/04/24 Last post  DrillDown2014 Comments Created with Sketch.  6  Views Created with Sketch.  1.6K 

See All Discussions arrow Created with Sketch.

Timeline

Notice under section 708A
02 May 17:39
 
Application for quotation of securities - CHM
02 May 17:34
 
Dr Rebecca McQualter appointed COO
02 May 09:59
 
Resignation of CEO and Managing Director
01 May 09:54
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:33
 
Change of Director's Interest Notice PH
08 Apr 17:03
 
View More arrow Created with Sketch.
(20min delay)
Last
2.9¢
Change
0.000(0.00%)
Mkt cap ! $24.70M
Open High Low Value Volume
2.9¢ 2.9¢ 2.8¢ $25.82K 913.8K

Buyers (Bids)

No. Vol. Price($)
6 5503899 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 301388 4
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
2.9¢
  Change
0.000 ( 3.57 %)
Open High Low Volume
2.8¢ 2.9¢ 2.7¢ 743366
Last updated 15.44pm 03/05/2024 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.